| Date Filed | Type | Description |
| 10/06/2023 |
4
| Shannon James Samuel (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 33,156 shares
@ $116.5, valued at
$3.9M
Disposed/sold 23,638 shares
@ $116.5, valued at
$2.8M
Disposed/sold 8,150 options to buy
@ $12.19, valued at
$99.3k
Disposed/sold 32,161 options to buy
@ $13.87, valued at
$446.1k
Disposed/sold 4,016 restricted stock units
@ $0 |
|
| 10/02/2023 |
4
| Shannon James Samuel (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Exercised 11,850 options to buy
@ $12.19, valued at
$144.5k
|
|
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2023 |
4
| Shannon James Samuel (Director) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 47,393 restricted stock units
@ $0 |
|
| 05/02/2023 |
4
| Shannon James Samuel (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Paid exercise price by delivering 1,879 shares
@ $111.16, valued at
$208.9k
Exercised 3,913 restricted stock units
@ $0 |
|
| 05/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2020 |
4
| Shannon James Samuel (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Exercised 8,204 shares
@ $0
Paid exercise price by delivering 3,221 shares
@ $61.19, valued at
$197.1k
Exercised 8,204 restricted stock units
@ $0 |
|
| 05/26/2020 |
4
| Shannon James Samuel (Director) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 88,235 restricted stock units
@ $0
Granted 38,760 restricted stock units
@ $0 |
|
| 05/04/2020 |
4
| Shannon James Samuel (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Exercised 15,390 shares
@ $0
Paid exercise price by delivering 6,041 shares
@ $35.62, valued at
$215.2k
Granted 11,098 restricted stock units
@ $0
Exercised 15,390 restricted stock units
@ $0 |
|
| 09/13/2019 |
4
| Shannon James Samuel (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Sold 15,500 shares
@ $26.5891, valued at
$412.1k
Sold 9,500 shares
@ $26.19, valued at
$248.8k
Exercised 15,500 options to buy
@ $12.19, valued at
$188.9k
Exercised 9,500 options to buy
@ $12.19, valued at
$115.8k
|
|
| 08/05/2019 |
4
| Shannon James Samuel (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Exercised 8,203 shares
@ $0
Paid exercise price by delivering 3,220 shares
@ $24.64, valued at
$79.3k
Exercised 8,203 restricted stock units
@ $0 |
|
| 05/16/2019 |
4
| Shannon James Samuel (Director) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 72,115 restricted stock units
@ $0
Granted 33,557 restricted stock units
@ $0 |
|
| 05/06/2019 |
4
| Shannon James Samuel (Director) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Exercised 15,320 shares
@ $0
Paid exercise price by delivering 6,014 shares
@ $26.54, valued at
$159.6k
Granted 15,390 restricted stock units
@ $0
Exercised 15,320 restricted stock units
@ $0 |
|
| 08/02/2018 |
4
| Shannon James Samuel (Director) has filed a Form 4 on Horizon Pharma plc|
Txns:
| Exercised 8,203 shares
@ $0
Paid exercise price by delivering 3,220 shares
@ $18.18, valued at
$58.5k
Exercised 8,203 restricted stock units
@ $0 |
|
| 05/22/2018 |
4/A
| Shannon James Samuel (Director) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 65,200 restricted stock units
@ $0 |
|
| 05/18/2018 |
4
| Shannon James Samuel (Director) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 65,200 restricted stock units
@ $0 |
|
| 05/07/2018 |
4
| Shannon James Samuel (Director) has filed a Form 4 on Horizon Pharma plc|
Txns:
| Granted 32,161 options to buy
@ $13.87, valued at
$446.1k
Granted 15,320 restricted stock units
@ $0 |
|
| 08/03/2017 |
4
| Shannon James Samuel (Director) has filed a Form 4 on Horizon Pharma plc|
Txns:
| Granted 52,232 options to buy
@ $12.19, valued at
$636.7k
Granted 24,610 restricted stock units
@ $0 |
|
| 08/03/2017 |
3
| Shannon James Samuel (Director) has filed a Form 3 on Horizon Pharma plc |
| 05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2017 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 06/02/2015 |
4
| Shannon James Samuel (Director) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 11,800 shares
@ $0
Granted 23,600 options to buy
@ $4.63, valued at
$109.3k
Granted 10,000 options to buy
@ $4.63, valued at
$46.3k
|
|
| 06/15/2011 |
4/A
| Shannon James Samuel (Director) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 7,188 shares
@ $0 |
|
| 06/07/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/31/2011 |
4
| Shannon James Samuel (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Granted 10,000 options to buy
@ $11.8, valued at
$118k
|
|
| 03/09/2011 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
| 03/01/2011 |
4
| Shannon James Samuel (Director) has filed a Form 4 on MANNKIND CORP|
Txns:
| Granted 5,142 shares
@ $0 |
|
| 02/11/2011 |
4
| Shannon James Samuel (Director) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Granted 2,617 options to buy
@ $7.23, valued at
$18.9k
|
|
| 02/04/2011 |
3
| Shannon James Samuel (Director) has filed a Form 3 on ENDOCYTE INC |
| 06/16/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|